These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19581182)

  • 1. [Cytogenetic and hormonal changes in head and neck squamous cell cancer patients: potential biomarkers for functional approaches in surgical oncology].
    Remenár E
    Magy Onkol; 2009 Jun; 53(2):157-64. PubMed ID: 19581182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum levels of sex steroid and pituitary hormones in chronic alcoholics and head and neck cancer patients as compared to normal controls].
    Remenár E; Számel I; Budai B; Gaudi I; Kásler M; Gundy S
    Magy Onkol; 2002; 46(4):329-32. PubMed ID: 12563355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Validity of chromosome analysis and bleomycin sensitivity assay in the prevention of head and neck cancer in Hungary].
    Székely G; Remenár E; Kásler M; Bodrog A; Gundy S
    Orv Hetil; 2001 Mar; 142(12):611-6. PubMed ID: 11324219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic significance of sex steroid and hypophyseal hormones in head and neck squamous cell carcinoma].
    Remenár E; Számel I; Budai B; Orosz Z; Gaudi I; Kásler M; Gundy S
    Magy Onkol; 2003; 47(2):155-9. PubMed ID: 12975662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
    Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of genetic susceptibility for development of squamous epithelial carcinomas of the had and neck with bleomycin-induced chromosome instability].
    Cloos J; Snow GB; Braakhuis BJ
    Laryngorhinootologie; 1995 Dec; 74(12):742-7. PubMed ID: 8579674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD44v6 is not a sensitive tumor marker in patients with head and neck squamous cell cancer.
    Andratschke M; Chaubal S; Pauli C; Mack B; Hagedorn H; Wollenberg B
    Anticancer Res; 2005; 25(4):2821-6. PubMed ID: 16080532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Problems occurring in the application of cytogenetic biomarkers for alcoholics with and without malignant diseases].
    Gundy S; Székely G; Farkas G; Pulay A; Remenár E
    Magy Onkol; 2008 Jun; 52(2):153-61. PubMed ID: 18640891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma.
    Cloos J; Leemans CR; van der Sterre ML; Kuik DJ; Snow GB; Braakhuis BJ
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):713-7. PubMed ID: 10919742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Steroid hormone receptors in squamous cell carcinoma of the head and neck].
    Budai B; Remenár E; Orosz Z; Számel I; Kralovánszky J; Kásler M
    Orv Hetil; 1997 Mar; 138(12):723-7. PubMed ID: 9157342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The soluble interleukin-2 receptor--a marker for squamous cell carcinoma of the upper aerodigestive tract.
    Gottschlich S; Görögh T; Lippert BM; Niemann AM; Folz BJ; Werner JA
    Anticancer Res; 1997; 17(4B):2921-2. PubMed ID: 9329564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between XPC expression, genotype, and the risk of head and neck cancer.
    Yang M; Kang MJ; Choi Y; Kim CS; Lee SM; Park CW; Lee HS; Tae K
    Environ Mol Mutagen; 2005 May; 45(4):374-9. PubMed ID: 15657918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.
    Boldrup L; Coates PJ; Hedberg Y; Sjöström B; Dahlqvist A; Nylander K
    Int J Oncol; 2005 Dec; 27(6):1661-7. PubMed ID: 16273222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed analysis of serum cytokines as biomarkers in squamous cell carcinoma of the head and neck patients.
    Hathaway B; Landsittel DP; Gooding W; Whiteside TL; Grandis JR; Siegfried JM; Bigbee WL; Ferris RL
    Laryngoscope; 2005 Mar; 115(3):522-7. PubMed ID: 15744170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma.
    Van Hal NL; Van Dongen GA; Ten Brink CB; Heider KH; Rech-Weichselbraun I; Snow GB; Brakenhoff RH
    Clin Cancer Res; 1999 Nov; 5(11):3534-41. PubMed ID: 10589769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of tissue inhibitors of metalloproteinases (TIMP) on course and prognosis of head and neck squamous cell carcinoma].
    Klisho EV; Kondakova IV; Choĭnzonov EL; Shishkin DA; Cheremisina OV; Chuzhevskaia SIu
    Vopr Onkol; 2009; 55(6):717-21. PubMed ID: 20210014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck.
    Gokhale AS; Haddad RI; Cavacini LA; Wirth L; Weeks L; Hallar M; Faucher J; Posner MR
    Oral Oncol; 2005 Jan; 41(1):70-6. PubMed ID: 15598588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study.
    Dahlstrom KR; Little JA; Zafereo ME; Lung M; Wei Q; Sturgis EM
    Head Neck; 2008 Jan; 30(1):75-84. PubMed ID: 17694557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 autoantibodies as tumor marker in head and neck squamous cell cancer.
    Gottschlich S; Hoffmann M; Maass JD; Görörgh T; Buhmann V; Hoffmann-Fazel A; Rudert H; Maune S
    Anticancer Res; 2003; 23(2A):913-5. PubMed ID: 12820322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.